The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending dupilumab as an add-on treatment to intranasal corticosteroids for adults with severe ...

USA: A new study from Memorial Sloan Kettering Cancer Center indicates that carefully selected patients with malignant colorectal polyps carrying high-risk features may be managed safely without ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

The figure was derived from‘International consensus on the management of large (≥20 mm) non-pedunculated colorectal polyps: A World Endoscopy Organisation Delphi study’; Djinbachian et al, 2023; Under ...

– In this 24-week study, VIBRANT met its primary endpoint, with verekitug dosed every 12 weeks leading to a statistically significant and clinically meaningful reduction from baseline in ...

Combination endoscopic sinus surgery (ESS) and biological therapy significantly decreased polyp burden in refractory chronic rhinosinusitis with nasal polyposis (CRSwNP) compared with biologic therapy ...

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...